Upmc Conemaugh Cancer Center
UPMC Conemaugh Cancer Center's assets have declined by over 87% in eight years, while revenue has decreased by 45% since 2016.
EIN: 202671883 · Pittsburgh, PA · NTEE: E20 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $2.5M |
| Total Expenses | $3.4M |
| Program Spending | 85% |
| Net Assets | $427K |
| Transparency Score | 70/100 |
Is Upmc Conemaugh Cancer Center Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Upmc Conemaugh Cancer Center directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Upmc Conemaugh Cancer Center
Upmc Conemaugh Cancer Center (EIN: 202671883) is a nonprofit organization based in Pittsburgh, PA, classified under NTEE code E20. The organization reported total revenue of $2.5M and total assets of $510K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Upmc Conemaugh Cancer Center's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Upmc Conemaugh Cancer Center is a mid-size nonprofit that has been operating for 19 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of -4.0%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $3.4M |
| Total Expenses | $3.4M |
| Surplus / Deficit | +$0 |
| Total Assets | $642K |
| Total Liabilities | $215K |
| Net Assets | $427K |
| Operating Margin | 0.0% |
| Debt-to-Asset Ratio | 33.6% |
| Months of Reserves | 2.3 months |
Financial Health Grade: B
In 2023, Upmc Conemaugh Cancer Center reported a surplus of $0 with revenue exceeding expenses, holds 2.3 months of operating reserves (limited), has a debt-to-asset ratio of 33.6% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), Upmc Conemaugh Cancer Center's revenue has declined at a compound annual growth rate (CAGR) of -4.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -21.8% | -21.8% | -38.8% |
| 2022 | -2.1% | -2.1% | -16.3% |
| 2021 | +10.2% | +10.2% | -31.7% |
| 2020 | -7.8% | -7.8% | -24.3% |
| 2019 | -20.9% | -20.9% | -22.4% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2007 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Upmc Conemaugh Cancer Center with a Mission Score of 70 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Upmc Conemaugh Cancer Center allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $0, with revenue exceeding expenses.
- Debt-to-asset ratio: 33.6%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, suggesting that executive salaries are either not paid directly by this specific entity or are covered by a parent organization, which is a common structure within large healthcare systems like UPMC. This practice, while not inherently negative, can obscure the full picture of executive remuneration within the broader system.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Upmc Conemaugh Cancer Center's IRS 990 filings:
- Significant and consistent decline in total assets over the past eight years, from $5,205,558 in 2015 to $641,998 in 2023.
- Substantial decrease in annual revenue from $6,165,696 in 2016 to $3,404,962 in 2023, indicating a shrinking operational scale.
- Consistent 'break-even' financial reporting where revenue equals expenses, which, while not a deficit, could mask underlying financial shifts or a lack of surplus for future investment.
Strengths
The following positive indicators were identified for Upmc Conemaugh Cancer Center:
- Consistent reporting of 0% officer compensation, indicating transparency regarding direct executive pay from this specific entity.
- Maintains a positive net asset position, with assets exceeding liabilities in all reported periods (e.g., $641,998 assets vs. $215,412 liabilities in 2023).
- Consistent ability to match expenses with revenue, suggesting effective budget management within its operational scope.
Frequently Asked Questions about Upmc Conemaugh Cancer Center
Is Upmc Conemaugh Cancer Center a legitimate charity?
Based on AI analysis of IRS 990 filings, Upmc Conemaugh Cancer Center (EIN: 202671883) some concerns. Mission Score: 70/100. 3 red flags identified, 3 strengths noted.
How does Upmc Conemaugh Cancer Center spend its money?
Upmc Conemaugh Cancer Center directs 85% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Upmc Conemaugh Cancer Center tax-deductible?
Upmc Conemaugh Cancer Center is registered as a tax-exempt nonprofit (EIN: 202671883). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Upmc Conemaugh Cancer Center's spending goes to programs?
Upmc Conemaugh Cancer Center directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Upmc Conemaugh Cancer Center compare to similar nonprofits?
With a transparency score of 70/100 (Good), Upmc Conemaugh Cancer Center is above average for NTEE category E20 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Upmc Conemaugh Cancer Center located?
Upmc Conemaugh Cancer Center is headquartered in Pittsburgh, Pennsylvania and files with the IRS under EIN 202671883. It is classified under NTEE code E20.
How many years of IRS 990 filings does Upmc Conemaugh Cancer Center have?
Upmc Conemaugh Cancer Center has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $2.5M in total revenue.
Why have UPMC Conemaugh Cancer Center's assets decreased so significantly, from $5,205,558 in 2015 to $641,998 in 2023?
The filings do not provide a specific reason for the substantial decline in assets. This trend, alongside decreasing revenue, suggests a potential restructuring, divestment of assets, or a shift in financial management within the broader UPMC system.
What is the nature of the relationship between UPMC Conemaugh Cancer Center and the broader UPMC system, especially concerning financial reporting and executive compensation?
The consistent 0% officer compensation and the 'break-even' financial reporting suggest that this entity may operate as part of a larger integrated system where financial resources and executive oversight are managed at a higher level within UPMC. Further investigation into the consolidated financial statements of UPMC would be necessary to understand the full financial picture.
How does the decrease in revenue from $6,165,696 in 2016 to $3,404,962 in 2023 impact the center's ability to provide services?
A nearly 45% reduction in revenue over seven years, even with expenses matching revenue, could indicate a reduction in the scale of operations, services offered, or a shift in funding sources. The filings do not detail the specific impact on program delivery.
Filing History
IRS 990 filing history for Upmc Conemaugh Cancer Center showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Upmc Conemaugh Cancer Center's revenue has declined by 38.8%, moving from $5.6M to $3.4M. Total assets decreased by 81.4% over the same period, from $3.4M to $642K. Total functional expenses fell by 38.8%, from $5.6M to $3.4M. In its most recent filing year (2023), Upmc Conemaugh Cancer Center reported a surplus of $0, with revenue exceeding expenses. The organization holds $215K in liabilities against $642K in assets (debt-to-asset ratio: 33.6%), resulting in net assets of $427K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $3.4M | $3.4M | $642K | $215K | — | View 990 |
| 2022 | $4.4M | $4.4M | $1.0M | $275K | — | View 990 |
| 2021 | $4.5M | $4.5M | $1.3M | $269K | — | View 990 |
| 2020 | $4.0M | $4.0M | $1.8M | $493K | — | View 990 |
| 2019 | $4.4M | $4.4M | $2.4M | $130K | — | View 990 |
| 2018 | $5.5M | $5.5M | $3.1M | $154K | — | View 990 |
| 2017 | $5.2M | $5.2M | $3.4M | $206K | — | View 990 |
| 2016 | $6.2M | $6.2M | $3.9M | $146K | — | View 990 |
| 2015 | $5.3M | $5.3M | $5.2M | $176K | — | View 990 |
| 2014 | $5.6M | $5.6M | $4.7M | $144K | — | View 990 |
| 2013 | $7.2M | $7.2M | $3.9M | $240K | — | View 990 |
| 2012 | $7.7M | $7.7M | $3.2M | $240K | — | View 990 |
| 2011 | $5.6M | $5.6M | $3.4M | $226K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $3.4M, expenses of $3.4M, and assets of $642K (revenue -21.8% year-over-year).
- 2022: Revenue of $4.4M, expenses of $4.4M, and assets of $1.0M (revenue -2.1% year-over-year).
- 2021: Revenue of $4.5M, expenses of $4.5M, and assets of $1.3M (revenue +10.2% year-over-year).
- 2020: Revenue of $4.0M, expenses of $4.0M, and assets of $1.8M (revenue -7.8% year-over-year).
- 2019: Revenue of $4.4M, expenses of $4.4M, and assets of $2.4M (revenue -20.9% year-over-year).
- 2018: Revenue of $5.5M, expenses of $5.5M, and assets of $3.1M (revenue +7.2% year-over-year).
- 2017: Revenue of $5.2M, expenses of $5.2M, and assets of $3.4M (revenue -16.3% year-over-year).
- 2016: Revenue of $6.2M, expenses of $6.2M, and assets of $3.9M (revenue +16.8% year-over-year).
- 2015: Revenue of $5.3M, expenses of $5.3M, and assets of $5.2M (revenue -6.6% year-over-year).
- 2014: Revenue of $5.6M, expenses of $5.6M, and assets of $4.7M (revenue -21.1% year-over-year).
- 2013: Revenue of $7.2M, expenses of $7.2M, and assets of $3.9M (revenue -6.6% year-over-year).
- 2012: Revenue of $7.7M, expenses of $7.7M, and assets of $3.2M (revenue +37.9% year-over-year).
- 2011: Revenue of $5.6M, expenses of $5.6M, and assets of $3.4M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Upmc Conemaugh Cancer Center:
Data Sources and Methodology
This transparency report for Upmc Conemaugh Cancer Center is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.